| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill.
Correspondence to Christopher Mack, PhD, Department of Pathology, University of North Carolina, Chapel Hill, NC 27599-7525. E-mail cmack{at}med.unc.edu
Objective We have previously shown that smooth muscle cell (SMC) differentiation marker gene expression is regulated by the small GTPase, RhoA. The objective of the present study was to determine the contributions of the RhoA effectors, diaphanous 1 and 2 (mDia1 and mDia2), to this regulatory mechanism.
Methods and Results mDia1 and mDia2 are expressed highly in aortic SMCs and in a number of SMC-containing organs including bladder, lung, and esophagus. Activation of mDia1/2 signaling by RhoA strongly stimulated SMC-specific promoter activity in multiple cell-types including primary aortic SMCs, and stimulated endogenous SM
-actin expression in 10T1/2 cells. Expression of a dominant negative Dia1 variant that inhibits both mDia1 and mDia2 significantly decreased SMC-specific transcription in SMCs. The effects of mDia1 and mDia2 required the presence of SRF and the activity of the myocardin transcription factors and were dependent on changes in actin polymerization. Importantly, stimulation of mDia1/2 signaling synergistically enhanced the activities of the myocardin-related transcription factors, MRTF-A and MRTF-B, and this effect was attributable to increased nuclear localization of these factors.
Conclusions These results indicate that RhoA-dependent signaling through mDia1/2 and the MRTFs is important for SMC-specific gene expression in SMCs.
The RhoA effectors, mDia1 and mDia2, are strongly expressed in aortic SMCs and dramatically upregulate SMC-specific gene expression by stimulating the nuclear localization of the myocardin-related transcription factors. These results suggest that RhoA/mDia/MRTF signaling may serve to regulate SMC phenotype in response to extrinsic factors.
Key Words: diaphanous RhoA SRF myocardin smooth muscle
Related Article:
Arterioscler. Thromb. Vasc. Biol. 2007 27: 448-449.
This article has been cited by other articles:
![]() |
Y. Xie, E-J. Tan, S. Wee, E. Manser, L. Lim, and C.-G. Koh Functional interactions between phosphatase POPX2 and mDia modulate RhoA pathways J. Cell Sci., February 15, 2008; 121(4): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lockman, J. M. Taylor, and C. P. Mack The Histone Demethylase, Jmjd1a, Interacts With the Myocardin Factors to Regulate SMC Differentiation Marker Gene Expression Circ. Res., December 7, 2007; 101(12): e115 - e123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Kraemer and G. D. Schellenberg SUT-1 enables tau-induced neurotoxicity in C. elegans Hum. Mol. Genet., August 15, 2007; 16(16): 1959 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Larsson, X. Zhou, and L. M. Akyurek RhoA-Dependent Vascular Smooth Muscle Cell-Specific Transcription: Adding Diaphanous Formins to the Puzzle Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 448 - 449. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |